NAFDAC

Immune Therapeutics Announces

NAFDAC Approval for Marketing & Distribution of Lodonal™

LEARN MORE

Immune Therapeutics Emerges as a Key Player in Immunotherapy Field

bg-lab-1

100+ years

Combined experience
in laboratory
research & immunology

LEARN MORE

Discover more about
our research and technology

bg-lab-2

Immunology

research and investigation

LEARN MORE

Investing in a better and healthier
world today to see it tomorrow

bg-lab-3-2

Experience

in immunology
and treating
illnesses

LEARN MORE

Treatment for known
autoimmune disorders & cancers

Our Projects

Latest News

Intersting Facts

Our Progress

Nigeria 96%
Kenya 65%
CAR-T 50%
Cytocom 50%

International Manufacturer

acromax logoProviding safe, effective and innovative pharmaceutical products that contribute to the well-being and health of the people since 1972

Additional info

  • Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis

  • Immune Effects of Low-dose Naltrexone in ME/CFS